Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic’s payment disclosure plan

This article was originally published in The Gray Sheet

Executive Summary

Medtronic will begin annually disclosing payments made to U.S. physicians in March 2011, the firm announces Feb. 24. Medtronic joins Edwards Lifesciences and a handful of drug firms in opting to publicly report physician payments ahead of a possible mandate from Congress, though both device firms set a less stringent reporting bar. Like Edwards, Medtronic will report payments made to physicians who receive $5,000 or more in consulting fees, royalties and honoraria from the firm (1"The Gray Sheet" Jan. 5, 2009, p. 23). Medtronic will start capturing payment data on Jan. 1, 2010, with annual third-party auditing. The latest version of the Physician Payments Sunshine Act, introduced Jan. 22, would require disclosure of all payments to a physician exceeding $100 in a year (2"The Gray Sheet" Jan. 26, 2009, p. 8)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027167

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel